annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2024 were $1.64, up 8.6% year over year. The metric beat the Zacks Consensus Estimate by 0.6%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.49, up 4.2% from the year-ago quarterâs EPS.
Revenues
On a reported basis, fiscal first-quarter...
>>> Read more: ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.49, up 4.2% from the year-ago quarterâs EPS.
Revenues
On a reported basis, fiscal first-quarter...
>>> Read more: ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down
